Studies in vitamin E: biochemistry and molecular biology of tocopherol quinones.

Considering maternal dietary modulators for epigenetic regulation and programming of the fetal epigenome. Nutrients (2015) 0.82

Antioxidants Abrogate Alpha-Tocopherylquinone-Mediated Down-Regulation of the Androgen Receptor in Androgen-Responsive Prostate Cancer Cells. PLoS One (2016) 0.75

Formation and Biological Targets of Quinones: Cytotoxic versus Cytoprotective Effects. Chem Res Toxicol (2016) 0.75

Associations between serum vitamin E concentration and bone mineral density in the US elderly population. Osteoporos Int (2016) 0.75

Generating a prion with bacterially expressed recombinant prion protein. Science (2010) 6.26

Isolation of phosphatidylethanolamine as a solitary cofactor for prion formation in the absence of nucleic acids. Proc Natl Acad Sci U S A (2012) 1.97

A common polymorphism in the upstream promoter region of the hepatocyte nuclear factor-4 alpha gene on chromosome 20q is associated with type 2 diabetes and appears to contribute to the evidence for linkage in an ashkenazi jewish population. Diabetes (2004) 1.83

Cofactor molecules maintain infectious conformation and restrict strain properties in purified prions. Proc Natl Acad Sci U S A (2012) 1.77

Lipid interaction converts prion protein to a PrPSc-like proteinase K-resistant conformation under physiological conditions. Biochemistry (2007) 1.62

Mechanism of arylating quinone toxicity involving Michael adduct formation and induction of endoplasmic reticulum stress. Proc Natl Acad Sci U S A (2006) 1.43

dELL is an essential RNA polymerase II elongation factor with a general role in development. Proc Natl Acad Sci U S A (2002) 1.34

Role of the highly conserved middle region of prion protein (PrP) in PrP-lipid interaction. Biochemistry (2010) 1.11

Genetic informational RNA is not required for recombinant prion infectivity. J Virol (2011) 1.10

Cofactor molecules induce structural transformation during infectious prion formation. Structure (2013) 1.05

Seeding specificity and ultrastructural characteristics of infectious recombinant prions. Biochemistry (2011) 1.04

De novo generation of infectious prions with bacterially expressed recombinant prion protein. FASEB J (2013) 0.97

Generation of goats lacking prion protein. Mol Reprod Dev (2009) 0.96

Conversion of bacterially expressed recombinant prion protein. Methods (2010) 0.95

The interaction between cytoplasmic prion protein and the hydrophobic lipid core of membrane correlates with neurotoxicity. J Biol Chem (2006) 0.91

Tocopherol metabolism using thermochemolysis: chemical and biological properties of gamma-tocopherol, gamma-carboxyethyl-hydroxychroman, and their quinones. Chem Res Toxicol (2005) 0.90

Calpain and other cytosolic proteases can contribute to the degradation of retro-translocated prion protein in the cytosol. J Biol Chem (2004) 0.88

Cytoplasmic prion protein induces forebrain neurotoxicity. Biochim Biophys Acta (2009) 0.86

Nutritional benefit of olive oil: the biological effects of hydroxytyrosol and its arylating quinone adducts. J Agric Food Chem (2008) 0.84

Context-dependent perturbation of neural systems in transgenic mice expressing a cytosolic prion protein. Neuroimage (2009) 0.83

Quinoprotein adducts accumulate in the substantia nigra of aged rats and correlate with dopamine-induced toxicity in SH-SY5Y cells. Neurochem Res (2011) 0.81

Silencing prion protein in MDA-MB-435 breast cancer cells leads to pleiotropic cellular responses to cytotoxic stimuli. PLoS One (2012) 0.79

Searching for type 2 diabetes genes on chromosome 20. Diabetes (2002) 0.79

Role of lipid in forming an infectious prion? Acta Biochim Biophys Sin (Shanghai) (2013) 0.78

How strong is the evidence that Parkinson's disease is a prion disorder? Curr Opin Neurol (2016) 0.75